Literature DB >> 2899129

Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis.

M Czub1, H R Braig, H Diringer.   

Abstract

Following intracerebral infection of hamsters with scrapie agent replication started with or without a very short lag phase. Infectivity titres increased exponentially within 35 to 40 days post-infection to a maximum level of 3 x 10(9) LD50 per brain and then remained constant until death. Minimal detectable amounts of scrapie-associated fibrils (SAF) appeared at 42 days and reached high levels 56 days after inoculation. The first clinical symptoms were diagnosed at about 65 days and animals died after 85 to 95 days. These data confirm earlier results in which peripheral infection first revealed agent replication, then SAF formation and finally clinical disease. Unconventional virus diseases, therefore, can best be described as virus-induced, organ-specific amyloidoses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899129     DOI: 10.1099/0022-1317-69-7-1753

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Neuronal autophagy in experimental scrapie.

Authors:  J W Boellaard; M Kao; W Schlote; H Diringer
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 3.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

4.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Neuronal autophagy in experimental Creutzfeldt-Jakob's disease.

Authors:  J W Boellaard; W Schlote; J Tateishi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Attempts to restore scrapie prion infectivity after exposure to protein denaturants.

Authors:  S B Prusiner; D Groth; A Serban; N Stahl; R Gabizon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

Review 8.  Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.

Authors:  S A Priola; B Caughey
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

9.  A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population.

Authors:  E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

10.  Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection.

Authors:  D McKenzie; J Kaczkowski; R Marsh; J Aiken
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.